Skip to main content

Table 2 Clinical correlation of the positive nucleic acid amplification test (NAAT) results in 2014 in the 4 laboratories that introduced NAATs as a second- or third-line test

From: Impact of the introduction of a nucleic acid amplification test for Clostridium difficile diagnosis on stool rejection policies

Laboratory Number of positive NAAT results Number of patients Chart review in favor of CDI
A 10 9 9 (100.0%)
B 46 41 39 (95.1%)
C 20 15 14 (93.3%)
D 14 8 8 (100.0%)
Total 90 73 70 (95.8%)
  1. The chart review was based on the clinical definition of C. difficile infection in the ESCMID recommendations [1]